Search - tctmd.com

Displaying 61 - 80 of 419

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Post LAA Closure Anticoagulation/Antiplatelet Regimens: Data and Practice

Presenter: Josep Rodés-Cabau

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

LAA Closure Plus: TAVR, MitraClip, PFO Closure, and More

Presenter: Ramon Quesada

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Submassive PE, Paradoxical Embolism, Residual DVT, and Large PFO: Thrombolysis, Filter, or Both?

Presenter: Horst Sievert, Robert J. Sommer, Varda Singhal, MD

June 22, 2018

Program Update: The LOTUS TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presentation The Structural Heart Disease Summit 2018

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Ted Feldman

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Presenter: Francesco Maisano

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Use of Appendage Lobe to Deploy Watchman Device in a Very Shallow Left Atrial Appendage: Access Is Success

Presenter: Horst Sievert, Robert J. Sommer, Sandeep Sehgal, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Presenter: David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Conductor (Illustrative Cases)

Presenter: Tamim Nazif

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies

Presenter: Shephal Doshi, Josep Rodés-Cabau, Steven J. Yakubov

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Successful Retrieval of Embolized Left Atrial Appendage Closure Device (Watchman) Utilizing a Cook Vascular Retrieval Forceps

Presenter: Horst Sievert, Robert J. Sommer, Zaher Fanari, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Trans-septal Puncture for Superiorly Directed Lobes

Presenter: Horst Sievert, Robert J. Sommer, Gagan Singh, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, John G. Webb

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Presenter: David J. Cohen

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Amulet Tips and Tricks in Simple and Complex Anatomy (With Case Reviews)

Presenter: Shephal Doshi, Josep Rodés-Cabau, DJ Lakkireddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Presenter: Brian R Lindman

June 22, 2018

Advertisement

Post LAA Closure Anticoagulation/Antiplatelet Regimens: Data and Practice

LAA Closure Plus: TAVR, MitraClip, PFO Closure, and More

Submassive PE, Paradoxical Embolism, Residual DVT, and Large PFO: Thrombolysis, Filter, or Both?

Program Update: The LOTUS Edge TAVR System: Design Characteristics, Clinical Data, and Future Vision

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Early Commercial Experience Using the PORTICO Transcatheter Aortic Valve: 30-Day Outcomes in 973 Patients Enrolled in the Portico I Study (Cohort A)

Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders?

Use of Appendage Lobe to Deploy Watchman Device in a Very Shallow Left Atrial Appendage: Access Is Success

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Conductor (Illustrative Cases)

The Epicardial Approach: Lariat Indications, Technique, Outcomes, and Ongoing Studies

Successful Retrieval of Embolized Left Atrial Appendage Closure Device (Watchman) Utilizing a Cook Vascular Retrieval Forceps

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Trans-septal Puncture for Superiorly Directed Lobes

Program Update: The SAPIEN 3 TAVR System - Design Characteristics, Clinical Data, and Future Vision

Keynote Lecture #3: A Deep Dive Into TAVR Cost-effectiveness Studies - Take-home Messages

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Amulet Tips and Tricks in Simple and Complex Anatomy (With Case Reviews)

Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Keynote Lecture #2: Useful and Evolving Biomarkers in Aortic Stenosis and TAVR - Current Status and Future Directions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content